Nanoencapsulation of Hirudo medicinalis proteins in liposomes as a nanocarrier for inhibiting angiogenesis through targeting VEGFA in the Breast cancer cell line (MCF-7)

Amir Shakouri ^1,2 , Houman Kahroba ², Hamed Hamishekar ¹, Jalal Abdolalizadeh ^3,4 *

Cited by CrossRef: 1

1- Li X, Zhou J, Wang X, Li C, Ma Z, Wan Q, Peng F. New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis. Biomedicine & Pharmacotherapy. 2023;163:114806 [Crossref]

2- Dong B, Li C, Xu X, Wang Y, Li Y, Li X. LncRNA LINC01123 promotes malignancy of ovarian cancer by targeting hsa-miR-516b-5p/VEGFA. Genes Genom. 2024;46(2):231 [Crossref]

3- Sabaghi Y, PourFarzad F, Zolghadr L, Bahrami A, Shojazadeh T, Farasat A, Gheibi N. A nano-liposomal carrier containing p-coumaric acid for induction of targeted apoptosis on melanoma cells and kinetic modeling. Biochemical and Biophysical Research Communications. 2024;690:149219 [Crossref]

4- Dong J, Chen J, Li Q, Qiu S. Magnetic Double Hydrogen Artesunate Nano Liposome on CAL Tongue Squamous Carcinoma and Laryngeal Hep-2-27 Cell Lines: An In Vitro Study. j biomed nanotechnol. 2024;20(1):157 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons